Literature DB >> 10374716

Role of protein kinase C and cAMP in fluoxetine effects on human T-cell proliferation.

V A Edgar1, L Sterin-Borda, G A Cremaschi, A M Genaro.   

Abstract

In this work, we studied the effect of fluoxetine on human T-lymphocyte proliferation using optimal and suboptimal concanavalin A concentrations. In particular, we analyzed the influence of fluoxetine on the kinases that are involved in intracellular signalling after stimulation with mitogens. We found that fluoxetine promoted the Ca2+ -mediated proteolysis of protein kinase C (PKC) and increased cyclic-AMP (cAMP) levels, thereby impairing lymphocyte proliferation, when optimal concanavalin A concentrations were used. In contrast, when suboptimal concanavalin A concentrations were used, fluoxetine only increased PKC translocation, without modifying cAMP levels, leading to T-cell proliferation. According to our results, fluoxetine has a dual effect on T-cell proliferation by modulating the PKC and protein kinase A pathways. This mechanism is thought to be mediated through Ca2+ mobilization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10374716     DOI: 10.1016/s0014-2999(99)00142-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Selective serotonin reuptake inhibitors facilitate ANO6 (TMEM16F) current activation and phosphatidylserine exposure.

Authors:  Hyun Jong Kim; Ikhyun Jun; Jae Seok Yoon; Jinsei Jung; Yung Kyu Kim; Woo Kyung Kim; Byung Joo Kim; Jaewoo Song; Sung Joon Kim; Joo Hyun Nam; Min Goo Lee
Journal:  Pflugers Arch       Date:  2015-01-30       Impact factor: 3.657

2.  Imipramine attenuates neuroinflammatory signaling and reverses stress-induced social avoidance.

Authors:  Karol Ramirez; Daniel T Shea; Daniel B McKim; Brenda F Reader; John F Sheridan
Journal:  Brain Behav Immun       Date:  2015-02-18       Impact factor: 7.217

Review 3.  Neuroimmune pharmacology of neurodegenerative and mental diseases.

Authors:  Feng-Shiun Shie; Yun-Hsiang Chen; Chia-Hsiang Chen; Ing-Kang Ho
Journal:  J Neuroimmune Pharmacol       Date:  2010-09-07       Impact factor: 4.147

4.  Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters.

Authors:  Carmine M Pariante; Richard B Kim; Andrew Makoff; Robert W Kerwin
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

5.  Fluoxetine reduces murine graft-versus-host disease by induction of T cell immunosuppression.

Authors:  Veerle Gobin; Katleen Van Steendam; Sabine Fevery; Kelly Tilleman; An D Billiau; Damiaan Denys; Dieter L Deforce
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-04       Impact factor: 4.147

6.  Antidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanisms.

Authors:  L A Carvalho; B A Garner; T Dew; H Fazakerley; C M Pariante
Journal:  Eur Neuropsychopharmacol       Date:  2010-03-15       Impact factor: 4.600

Review 7.  Neuroimmunological mechanism of pruritus in atopic dermatitis focused on the role of serotonin.

Authors:  Kwangmi Kim
Journal:  Biomol Ther (Seoul)       Date:  2012-11       Impact factor: 4.634

8.  The antidepressant fluoxetine induces necrosis by energy depletion and mitochondrial calcium overload.

Authors:  Emilie Charles; Mehdi Hammadi; Philippe Kischel; Vanessa Delcroix; Nicolas Demaurex; Cyril Castelbou; Anne-Marie Vacher; Anne Devin; Thomas Ducret; Paula Nunes; Pierre Vacher
Journal:  Oncotarget       Date:  2017-01-10

9.  Potentiation of Schaffer-Collateral CA1 Synaptic Transmission by eEF2K and p38 MAPK Mediated Mechanisms.

Authors:  Weiguang Weng; Ying Chen; Man Wang; Yinghan Zhuang; Thomas Behnisch
Journal:  Front Cell Neurosci       Date:  2016-10-25       Impact factor: 5.505

10.  Serotonin stimulated parathyroid hormone related protein induction in the mammary epithelia by transglutaminase-dependent serotonylation.

Authors:  Celeste M Sheftel; Laura L Hernandez
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.